New pill could tame painful skin condition
NCT ID NCT07417917
First seen Feb 19, 2026 · Last updated May 23, 2026 · Updated 8 times
Summary
This study tests a new capsule called QLS12010 in 102 adults with moderate-to-severe hidradenitis suppurativa (HS), a painful skin condition. The trial has two parts: first, an open-label phase to see if the drug works and is safe; second, a placebo-controlled phase to find the best dose. Participants will be treated for up to 24 weeks and followed for 4 more weeks to check for side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADULTS WITH MODERATE-TO-SEVERE HIDRADENITIS SUPPURATIVA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.